News
Obefazimod shows efficacy and favourable safety in patients with moderate to severely active ulcerative colitis in a 96-week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback